You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
|
|---|---|
| Published in |
The Lancet, October 2021
|
| DOI | 10.1016/s0140-6736(21)01210-1 |
| Pubmed ID | |
| Authors |
Sube Banerjee, Juliet High, Susan Stirling, Lee Shepstone, Ann Marie Swart, Tanya Telling, Catherine Henderson, Clive Ballard, Peter Bentham, Alistair Burns, Nicolas Farina, Chris Fox, Paul Francis, Robert Howard, Martin Knapp, Iracema Leroi, Gill Livingston, Ramin Nilforooshan, Shirley Nurock, John O'Brien, Annabel Price, Alan J Thomas, Naji Tabet |
X Demographics
The data shown below were collected from the profiles of 439 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 87 | 20% |
| Spain | 45 | 10% |
| United States | 31 | 7% |
| Canada | 16 | 4% |
| Australia | 13 | 3% |
| Japan | 12 | 3% |
| France | 9 | 2% |
| Ireland | 7 | 2% |
| Mexico | 6 | 1% |
| Other | 46 | 10% |
| Unknown | 167 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 266 | 61% |
| Practitioners (doctors, other healthcare professionals) | 94 | 21% |
| Scientists | 73 | 17% |
| Science communicators (journalists, bloggers, editors) | 6 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 137 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 12 | 9% |
| Researcher | 11 | 8% |
| Student > Master | 10 | 7% |
| Student > Bachelor | 9 | 7% |
| Professor | 5 | 4% |
| Other | 27 | 20% |
| Unknown | 63 | 46% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 21% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Nursing and Health Professions | 6 | 4% |
| Agricultural and Biological Sciences | 5 | 4% |
| Psychology | 4 | 3% |
| Other | 20 | 15% |
| Unknown | 66 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 607. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2024.
All research outputs
#38,177
of 25,791,495 outputs
Outputs from The Lancet
#777
of 42,996 outputs
Outputs of similar age
#1,209
of 439,098 outputs
Outputs of similar age from The Lancet
#26
of 356 outputs
Altmetric has tracked 25,791,495 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,996 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 67.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,098 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 356 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.